Literature DB >> 21952639

NIRF constitutes a nodal point in the cell cycle network and is a candidate tumor suppressor.

Tsutomu Mori1, Daisuke D Ikeda, Toshihiko Fukushima, Seiichi Takenoshita, Hideo Kochi.   

Abstract

In biological networks, a small number of "hub" proteins play critical roles in the network integrity and functions. The cell cycle network orchestrates versatile cellular functions through interactions between many signaling modules, whose defects impair diverse cellular processes, often leading to cancer. However, the network architecture and molecular basis that ensure proper coordination between distinct modules are unclear. Here, we show that the ubiquitin ligase NIRF (also known as UHRF2), which induces G1 arrest, interacts with multiple cell cycle proteins including cyclins (A2, B1, D1 and E1), p53 and pRB, and ubiquitinates cyclins D1 and E1. Consistent with its versatility, a bioinformatic network analysis demonstrated that NIRF is an intermodular hub protein that is responsible for the coordination of multiple network modules. Notably, intermodular hubs are frequently associated with oncogenesis. Indeed, we detected loss of heterozygosity of the NIRF gene in several kinds of tumors. When a cancer outlier profile analysis was applied to the Oncomine database, loss of the NIRF gene was found at statistically significant levels in diverse tumors. Importantly, a recurrent microdeletion targeting NIRF was observed in non-small cell lung carcinoma. Furthermore, NIRF is immediately adjacent to the single nucleotide polymorphism rs719725, which is reportedly associated with the risk of colorectal cancer. These observations suggest that NIRF occupies a prominent position within the cell cycle network, and is a strong candidate for a tumor suppressor whose aberration contributes to the pathogenesis of diverse malignancies.
© 2011 Landes Bioscience

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21952639      PMCID: PMC3233626          DOI: 10.4161/cc.10.19.17176

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  83 in total

Review 1.  Cell-cycle checkpoints and cancer.

Authors:  Michael B Kastan; Jiri Bartek
Journal:  Nature       Date:  2004-11-18       Impact factor: 49.962

2.  Discovering disease-genes by topological features in human protein-protein interaction network.

Authors:  Jianzhen Xu; Yongjin Li
Journal:  Bioinformatics       Date:  2006-09-05       Impact factor: 6.937

3.  Integration of biological networks and gene expression data using Cytoscape.

Authors:  Melissa S Cline; Michael Smoot; Ethan Cerami; Allan Kuchinsky; Nerius Landys; Chris Workman; Rowan Christmas; Iliana Avila-Campilo; Michael Creech; Benjamin Gross; Kristina Hanspers; Ruth Isserlin; Ryan Kelley; Sarah Killcoyne; Samad Lotia; Steven Maere; John Morris; Keiichiro Ono; Vuk Pavlovic; Alexander R Pico; Aditya Vailaya; Peng-Liang Wang; Annette Adler; Bruce R Conklin; Leroy Hood; Martin Kuiper; Chris Sander; Ilya Schmulevich; Benno Schwikowski; Guy J Warner; Trey Ideker; Gary D Bader
Journal:  Nat Protoc       Date:  2007       Impact factor: 13.491

4.  Gene expression profiling allows distinction between primary and metastatic squamous cell carcinomas in the lung.

Authors:  Simon G Talbot; Cherry Estilo; Ellie Maghami; Inderpal S Sarkaria; Duy Khanh Pham; Pornchai O-charoenrat; Nicholas D Socci; Ivan Ngai; Diane Carlson; Ronald Ghossein; Agnes Viale; Bernard J Park; Valerie W Rusch; Bhuvanesh Singh
Journal:  Cancer Res       Date:  2005-04-15       Impact factor: 12.701

5.  A bipartite substrate recognition motif for cyclin-dependent kinases.

Authors:  D Y Takeda; J A Wohlschlegel; A Dutta
Journal:  J Biol Chem       Date:  2000-11-06       Impact factor: 5.157

6.  An algorithm for classifying tumors based on genomic aberrations and selecting representative tumor models.

Authors:  Xin Lu; Ke Zhang; Charles Van Sant; John Coon; Dimitri Semizarov
Journal:  BMC Med Genomics       Date:  2010-06-22       Impact factor: 3.063

7.  Cloning and mapping of Np95 gene which encodes a novel nuclear protein associated with cell proliferation.

Authors:  A Fujimori; Y Matsuda; Y Takemoto; Y Hashimoto; E Kubo; R Araki; R Fukumura; K Mita; K Tatsumi; M Muto
Journal:  Mamm Genome       Date:  1998-12       Impact factor: 2.957

8.  Is miR-29 an oncogene or tumor suppressor in CLL?

Authors:  Yuri Pekarsky; Carlo M Croce
Journal:  Oncotarget       Date:  2010-07

9.  Disease-aging network reveals significant roles of aging genes in connecting genetic diseases.

Authors:  Jiguang Wang; Shihua Zhang; Yong Wang; Luonan Chen; Xiang-Sun Zhang
Journal:  PLoS Comput Biol       Date:  2009-09-25       Impact factor: 4.475

10.  The importance of bottlenecks in protein networks: correlation with gene essentiality and expression dynamics.

Authors:  Haiyuan Yu; Philip M Kim; Emmett Sprecher; Valery Trifonov; Mark Gerstein
Journal:  PLoS Comput Biol       Date:  2007-02-14       Impact factor: 4.475

View more
  18 in total

1.  Flipping the switch from g1 to s phase with e3 ubiquitin ligases.

Authors:  Lindsay F Rizzardi; Jeanette Gowen Cook
Journal:  Genes Cancer       Date:  2012-11

2.  Multidimensional Proteomics Reveals a Role of UHRF2 in the Regulation of Epithelial-Mesenchymal Transition (EMT).

Authors:  Mi Lai; Lizhu Liang; Jiwei Chen; Naiqi Qiu; Sai Ge; Shuhui Ji; Tieliu Shi; Bei Zhen; Mingwei Liu; Chen Ding; Yi Wang; Jun Qin
Journal:  Mol Cell Proteomics       Date:  2016-04-25       Impact factor: 5.911

3.  The nuclear protein UHRF2 is a direct target of the transcription factor E2F1 in the induction of apoptosis.

Authors:  Huarui Lu; Timothy C Hallstrom
Journal:  J Biol Chem       Date:  2013-07-05       Impact factor: 5.157

4.  UHRF2 promotes Hepatocellular Carcinoma Progression by Upregulating ErbB3/Ras/Raf Signaling Pathway.

Authors:  Jingjie Sun; Kejia Wu; Siyuan Chen; Shiming Jiang; Yong Chen; Changzhu Duan
Journal:  Int J Med Sci       Date:  2021-06-26       Impact factor: 3.738

5.  UHRF2 regulates cell cycle, epigenetics and gene expression to control the timing of retinal progenitor and ganglion cell differentiation.

Authors:  Xiaohong Wang; Aaron L Sarver; Qiyuan Han; Christopher L Seiler; Chencheng Xie; Huarui Lu; Colleen L Forster; Natalia Y Tretyakova; Timothy C Hallstrom
Journal:  Development       Date:  2022-03-14       Impact factor: 6.862

6.  NVP-BEZ235, a novel dual PI3K/mTOR inhibitor, enhances the radiosensitivity of human glioma stem cells in vitro.

Authors:  Wen-juan Wang; Lin-mei Long; Neng Yang; Qing-qing Zhang; Wen-jun Ji; Jiang-hu Zhao; Zheng-hong Qin; Zhong Wang; Gang Chen; Zhong-qin Liang
Journal:  Acta Pharmacol Sin       Date:  2013-04-22       Impact factor: 6.150

7.  UHRF2, a ubiquitin E3 ligase, acts as a small ubiquitin-like modifier E3 ligase for zinc finger protein 131.

Authors:  Yohan Oh; Kwang Chul Chung
Journal:  J Biol Chem       Date:  2013-02-12       Impact factor: 5.157

Review 8.  Early human embryos are naturally aneuploid-can that be corrected?

Authors:  Amy Lee; Ann A Kiessling
Journal:  J Assist Reprod Genet       Date:  2016-11-29       Impact factor: 3.412

9.  Loss of UHRF2 expression is associated with human neoplasia, promoter hypermethylation, decreased 5-hydroxymethylcytosine, and high proliferative activity.

Authors:  Huarui Lu; Sweta Bhoopatiraju; Hongbo Wang; Nolan P Schmitz; Xiaohong Wang; Matthew J Freeman; Colleen L Forster; Michael R Verneris; Michael A Linden; Timothy C Hallstrom
Journal:  Oncotarget       Date:  2016-11-15

10.  WISP3 is highly expressed in a subset of colorectal carcinomas with a better prognosis.

Authors:  Yongliang Lu; Xiang Wang; Xinrong Sun; Wenming Feng; Huihui Guo; Chengwu Tang; Anmei Deng; Ying Bao
Journal:  Onco Targets Ther       Date:  2016-01-12       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.